Ovid Therapeutics (OVID) EPS (Diluted) Growth (1y) (2021 - 2026)
Ovid Therapeutics (OVID) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | -65.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.98% |
| Dec 31, 2025 | 204.43% |
| Sep 30, 2025 | 13.19% |
| Jun 30, 2025 | -155.14% |
| Mar 31, 2025 | 12.80% |
| Dec 31, 2024 | 39.95% |
| Sep 30, 2024 | -23.84% |
| Jun 30, 2024 | 168.03% |
| Mar 31, 2024 | 12.72% |
| Dec 31, 2023 | -32.89% |
| Sep 30, 2023 | 6.22% |
| Jun 30, 2023 | 15.12% |
| Mar 31, 2023 | 17.26% |
| Dec 31, 2022 | 57.23% |
| Sep 30, 2022 | -1.39% |
| Jun 30, 2022 | 10.98% |
| Mar 31, 2022 | -108.66% |
| Dec 31, 2021 | -1.35% |
| Sep 30, 2021 | 39.39% |
| Jun 30, 2021 | 42.59% |